Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Early versus later treatment start in multiple sclerosis: a register-based cohort study.

Chalmer TA, Baggesen LM, Nørgaard M, Koch-Henriksen N, Magyari M, Sorensen PS; Danish Multiple Sclerosis Group.

Eur J Neurol. 2018 May 30. doi: 10.1111/ene.13692. [Epub ahead of print]

PMID:
29847005
2.

Infections seem to be more frequent before onset of pediatric multiple sclerosis: A Danish nationwide nested case-control study.

Boesen MS, Koch-Henriksen N, Thygesen LC, Eriksson F, Greisen G, Born AP, Blinkenberg M, Uldall PV, Magyari M.

Mult Scler. 2018 May 1:1352458518771871. doi: 10.1177/1352458518771871. [Epub ahead of print]

PMID:
29770725
3.

Small-scale geographical variation in multiple sclerosis: A case-control study using Danish register data 1971-2013.

Bihrmann K, Nielsen NM, Magyari M, Koch-Henriksen N, Nordsborg RB, Ersbøll AK.

Mult Scler Relat Disord. 2018 May 4;23:40-45. doi: 10.1016/j.msard.2018.04.021. [Epub ahead of print]

4.

Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: a nationwide validation study.

Boesen MS, Blinkenberg M, Koch-Henriksen N, Thygesen LC, Uldall PV, Magyari M, Born AP.

Dev Med Child Neurol. 2018 May 10. doi: 10.1111/dmcn.13798. [Epub ahead of print]

PMID:
29744874
5.

Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women.

Koch-Henriksen N, Thygesen LC, Stenager E, Laursen B, Magyari M.

Neurology. 2018 May 29;90(22):e1954-e1963. doi: 10.1212/WNL.0000000000005612. Epub 2018 May 2.

PMID:
29720546
6.

Smoking affects the interferon beta treatment response in multiple sclerosis.

Petersen ER, Oturai AB, Koch-Henriksen N, Magyari M, Sørensen PS, Sellebjerg F, Søndergaard HB.

Neurology. 2018 Feb 13;90(7):e593-e600. doi: 10.1212/WNL.0000000000004949. Epub 2018 Jan 17.

PMID:
29343473
7.

Psychiatric morbidity develops after onset of pediatric multiple sclerosis: A Danish nationwide population-based study.

Boesen MS, Thygesen LC, Uldall PV, Eriksson F, Born AP, Blinkenberg M, Koch-Henriksen N, Greisen G, Magyari M.

Mult Scler Relat Disord. 2018 Jan;19:30-34. doi: 10.1016/j.msard.2017.10.018. Epub 2017 Oct 31.

PMID:
29121513
8.

Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.

Thormann A, Sørensen PS, Koch-Henriksen N, Laursen B, Magyari M.

Neurology. 2017 Oct 17;89(16):1668-1675. doi: 10.1212/WNL.0000000000004508. Epub 2017 Sep 20.

PMID:
28931645
9.

Dietary sodium intake: An etiologic dead end in multiple sclerosis.

Koch-Henriksen N, Lauer K.

Neurology. 2017 Sep 26;89(13):1314-1315. doi: 10.1212/WNL.0000000000004426. Epub 2017 Aug 25. No abstract available.

PMID:
28842448
10.

Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study.

Koch-Henriksen N, Laursen B, Stenager E, Magyari M.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):626-631. doi: 10.1136/jnnp-2017-315907.

PMID:
28705951
11.

Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: A nationwide population-based incidence study.

Boesen MS, Magyari M, Koch-Henriksen N, Thygesen LC, Born AP, Uldall PV, Blinkenberg M.

Mult Scler. 2018 Jul;24(8):1077-1086. doi: 10.1177/1352458517713669. Epub 2017 Jun 13.

PMID:
28608742
12.

Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships.

Thormann A, Sørensen PS, Koch-Henriksen N, Thygesen LC, Laursen B, Magyari M.

Eur J Neurol. 2017 Jun;24(6):825-834. doi: 10.1111/ene.13297.

PMID:
28544411
13.

Age at Menarche and Risk of Multiple Sclerosis: A Prospective Cohort Study Based on the Danish National Birth Cohort.

Nielsen NM, Harpsøe M, Simonsen J, Stenager E, Magyari M, Koch-Henriksen N, Baker JL, Hjalgrim H, Frisch M, Bager P.

Am J Epidemiol. 2017 Apr 15;185(8):712-719. doi: 10.1093/aje/kww160.

PMID:
28369233
14.

Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort.

Thormann A, Koch-Henriksen N, Laursen B, Sørensen PS, Magyari M.

Mult Scler Relat Disord. 2016 Nov;10:181-186. doi: 10.1016/j.msard.2016.10.008. Epub 2016 Oct 29.

PMID:
27919487
15.

Early safety and efficacy of fingolimod treatment in Denmark.

Voldsgaard A, Koch-Henriksen N, Magyari M, Sellebjerg F, Sørensen PS, Oturai AB.

Acta Neurol Scand. 2017 Jan;135(1):129-133. doi: 10.1111/ane.12573. Epub 2016 Mar 8.

PMID:
27910101
16.

Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A.

Neurology. 2017 Jan 3;88(1):44-51. doi: 10.1212/WNL.0000000000003454. Epub 2016 Nov 30.

17.

The Danish Multiple Sclerosis Treatment Register.

Magyari M, Koch-Henriksen N, Sørensen PS.

Clin Epidemiol. 2016 Oct 25;8:549-552. eCollection 2016. Review.

18.

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.

Bachelet D, Hässler S, Mbogning C, Link J, Ryner M, Ramanujam R, Auer M, Hyldgaard Jensen PE, Koch-Henriksen N, Warnke C, Ingenhoven K, Buck D, Grummel V, Lawton A, Donnellan N, Hincelin-Mery A, Sikkema D, Pallardy M, Kieseier B, Hemmer B, Hartung HP, Soelberg Sorensen P, Deisenhammer F, Dönnes P, Davidson J, Fogdell-Hahn A, Broët P; ABIRISK Consortium.

PLoS One. 2016 Nov 2;11(11):e0162752. doi: 10.1371/journal.pone.0162752. eCollection 2016.

19.

Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Thormann A, Magyari M, Koch-Henriksen N, Laursen B, Sørensen PS.

J Neurol. 2016 Dec;263(12):2484-2493. Epub 2016 Oct 3.

PMID:
27699465
20.

Employment, disability pension and income for children with parental multiple sclerosis.

Moberg JY, Laursen B, Koch-Henriksen N, Thygesen LC, Brødsgaard A, Soelberg Sørensen P, Magyari M.

Mult Scler. 2017 Jul;23(8):1148-1156. doi: 10.1177/1352458516672016. Epub 2016 Sep 28.

PMID:
27682230
21.

Educational achievements of children of parents with multiple sclerosis: A nationwide register-based cohort study.

Moberg JY, Magyari M, Koch-Henriksen N, Thygesen LC, Laursen B, Soelberg Sørensen P.

J Neurol. 2016 Nov;263(11):2229-2237. Epub 2016 Aug 19.

PMID:
27541043
22.

A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.

Koch-Henriksen N, Magyari M, Sellebjerg F, Soelberg Sørensen P.

Mult Scler. 2017 Feb;23(2):234-241. doi: 10.1177/1352458516643393. Epub 2016 Jul 11.

PMID:
27055806
23.

Self-rated health in women prior to clinical onset of multiple sclerosis: A study within the Danish National Birth Cohort.

Nielsen NM, Harpsøe MC, Simonsen J, Stenager E, Magyari M, Koch-Henriksen N, Frisch M, Bager P.

Mult Scler. 2016 Oct;22(11):1444-1451. Epub 2016 Jan 8.

PMID:
26746810
24.

Physical and social environment and the risk of multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS.

Mult Scler Relat Disord. 2014 Sep;3(5):600-6. doi: 10.1016/j.msard.2014.07.002. Epub 2014 Jul 21.

PMID:
26265272
25.

Registers of multiple sclerosis in Denmark.

Koch-Henriksen N, Magyari M, Laursen B.

Acta Neurol Scand. 2015;132(199):4-10. doi: 10.1111/ane.12424. Review.

PMID:
26046552
26.

Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis.

Laursen JH, Søndergaard HB, Albrechtsen A, Frikke-Schmidt R, Koch-Henriksen N, Soelberg Sørensen P, Sellebjerg F, Oturai A.

Mult Scler. 2015 Oct;21(11):1414-22. doi: 10.1177/1352458514563590. Epub 2014 Dec 22.

PMID:
25533295
27.

Gender effects on treatment response to interferon-beta in multiple sclerosis.

Magyari M, Koch-Henriksen N, Laursen B, Sørensen PS.

Acta Neurol Scand. 2014 Dec;130(6):374-9. doi: 10.1111/ane.12277. Epub 2014 Sep 10.

PMID:
25208455
28.

The use of valproic acid and multiple sclerosis.

Nielsen NM, Svanström H, Stenager E, Magyari M, Koch-Henriksen N, Pasternak B, Hviid A.

Pharmacoepidemiol Drug Saf. 2015 Mar;24(3):262-8. doi: 10.1002/pds.3692. Epub 2014 Aug 11.

PMID:
25111895
29.

Prediction of response to interferon therapy in multiple sclerosis.

Sellebjerg F, Søndergaard HB, Koch-Henriksen N, Sørensen PS, Oturai AB.

Acta Neurol Scand. 2014 Oct;130(4):268-75. doi: 10.1111/ane.12269. Epub 2014 Jun 18.

PMID:
24943672
30.

Multiple sclerosis registries in Europe - results of a systematic survey.

Flachenecker P, Buckow K, Pugliatti M, Kes VB, Battaglia MA, Boyko A, Confavreux C, Ellenberger D, Eskic D, Ford D, Friede T, Fuge J, Glaser A, Hillert J, Holloway E, Ioannidou E, Kappos L, Kasilingam E, Koch-Henriksen N, Kuhle J, Lepore V, Middleton R, Myhr KM, Orologas A, Otero S, Pitschnau-Michel D, Rienhoff O, Sastre-Garriga J, Schyns-Liharska T, Sutovic D, Thalheim C, Trojano M, Vlasov YV, Yaldizli O; EUReMS Consortium.

Mult Scler. 2014 Oct;20(11):1523-32. doi: 10.1177/1352458514528760. Epub 2014 Apr 28.

PMID:
24777278
31.

Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients.

Sorensen PS, Koch-Henriksen N, Petersen T, Ravnborg M, Oturai A, Sellebjerg F.

J Neurol. 2014 Jun;261(6):1170-7. doi: 10.1007/s00415-014-7325-8. Epub 2014 Apr 12.

PMID:
24728334
32.

Stressful life-events in childhood and risk of multiple sclerosis: a Danish nationwide cohort study.

Nielsen NM, Pedersen BV, Stenager E, Koch-Henriksen N, Frisch M.

Mult Scler. 2014 Oct;20(12):1609-15. doi: 10.1177/1352458514528761. Epub 2014 Mar 31.

PMID:
24687805
33.

Major stressful life events in adulthood and risk of multiple sclerosis.

Nielsen NM, Bager P, Simonsen J, Hviid A, Stenager E, Brønnum-Hansen H, Koch-Henriksen N, Frisch M.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1103-8. doi: 10.1136/jnnp-2013-307181. Epub 2014 Mar 7.

PMID:
24610940
34.

Gender and autoimmune comorbidity in multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS.

Mult Scler. 2014 Aug;20(9):1244-51. doi: 10.1177/1352458514521515. Epub 2014 Feb 5.

PMID:
24500604
35.

Alternative data sources for estimating multiple sclerosis prevalence.

Koch-Henriksen N.

Mult Scler. 2013 Nov;19(13):1682-3. doi: 10.1177/1352458513511879. No abstract available.

PMID:
24218485
36.

Multiple sclerosis and risk of Parkinson's disease: a Danish nationwide cohort study.

Nielsen NM, Pasternak B, Stenager E, Koch-Henriksen N, Frisch M.

Eur J Neurol. 2014;21(1):107-11. doi: 10.1111/ene.12255. Epub 2013 Sep 19.

PMID:
24053187
37.

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

Møller M, Søndergaard HB, Koch-Henriksen N, Sorensen PS, Sellebjerg F, Oturai AB.

Acta Neurol Scand. 2014 Jan;129(1):27-31. doi: 10.1111/ane.12145. Epub 2013 May 14.

PMID:
23668375
38.

Socioeconomic factors in childhood and the risk of multiple sclerosis.

Nielsen NM, Jørgensen KT, Bager P, Stenager E, Pedersen BV, Hjalgrim H, Koch-Henriksen N, Frisch M.

Am J Epidemiol. 2013 Jun 1;177(11):1289-95. doi: 10.1093/aje/kws350. Epub 2013 May 9.

PMID:
23660795
39.

Childhood body mass index and multiple sclerosis risk: a long-term cohort study.

Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sørensen TI, Baker JL.

Mult Scler. 2013 Sep;19(10):1323-9. doi: 10.1177/1352458513483889. Epub 2013 Apr 2.

40.

Reproduction and the risk of multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS.

Mult Scler. 2013 Oct;19(12):1604-9. doi: 10.1177/1352458513481397. Epub 2013 Mar 18.

PMID:
23508651
41.

Cesarean section and offspring's risk of multiple sclerosis: a Danish nationwide cohort study.

Nielsen NM, Bager P, Stenager E, Pedersen BV, Koch-Henriksen N, Hjalgrim H, Frisch M.

Mult Scler. 2013 Oct;19(11):1473-7. doi: 10.1177/1352458513480010. Epub 2013 Mar 6.

PMID:
23466398
42.

A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.

Galea I, Lederer C, Neuhaus A, Muraro PA, Scalfari A, Koch-Henriksen N, Heesen C, Koepke S, Stellmann P, Albrecht H, Winkelmann A, Weber F, Bahn E, Hauser M, Edan G, Ebers G, Daumer M.

Eur J Neurol. 2013 Jul;20(7):1107-9. doi: 10.1111/ene.12016. Epub 2012 Dec 7.

43.

Treatment of HIV and risk of multiple sclerosis.

Nexø BA, Pedersen L, Sørensen HT, Koch-Henriksen N.

Epidemiology. 2013 Mar;24(2):331-2. doi: 10.1097/EDE.0b013e318281e48a. No abstract available.

PMID:
23377093
44.

The use of epidemiological multiple sclerosis registers in research: the Danish MS Registry.

Koch-Henriksen N, Stenager E, Laursen B.

Acta Neurol Scand Suppl. 2012;(195):7-12. doi: 10.1111/ane.12022.

PMID:
23278650
45.

[Multiple Sclerosis Treatment Registry].

Thirup P, Koch-Henriksen N, Sørensen PS.

Ugeskr Laeger. 2012 Oct 15;174(42):2537. Danish. No abstract available.

PMID:
23079440
46.

Prediction of antibody persistency from antibody titres to natalizumab.

Jensen PE, Koch-Henriksen N, Sellebjerg F, Sørensen PS.

Mult Scler. 2012 Oct;18(10):1493-9. Epub 2012 Mar 27.

PMID:
22454098
47.

Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers.

Bazelier MT, de Vries F, Bentzen J, Vestergaard P, Leufkens HG, van Staa TP, Koch-Henriksen N.

Mult Scler. 2012 May;18(5):622-7. doi: 10.1177/1352458511426739. Epub 2011 Oct 21.

PMID:
22020418
48.

Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?

Koch-Henriksen N, Sorensen PS.

J Neurol Sci. 2011 Dec 15;311(1-2):58-63. doi: 10.1016/j.jns.2011.09.003. Epub 2011 Oct 7. Review.

PMID:
21982346
49.

Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study.

Nørgaard M, Nielsen RB, Jacobsen JB, Gradus JL, Stenager E, Koch-Henriksen N, Lash TL, Sørensen HT.

Am J Epidemiol. 2011 Oct 15;174(8):945-8. doi: 10.1093/aje/kwr201. Epub 2011 Sep 13.

PMID:
21920946
50.

Studies based on the Danish Multiple Sclerosis Registry.

Koch-Henriksen N, Stenager E, Brønnum-Hansen H.

Scand J Public Health. 2011 Jul;39(7 Suppl):180-4. doi: 10.1177/1403494811405097. Review.

PMID:
21775380

Supplemental Content

Loading ...
Support Center